Clinical Trials Directory

Trials / Completed

CompletedNCT03883828

Bacterial Decolonization to Prevent Radiation Dermatitis

Bacterial Decolonization to Prevent Radiation Dermatitis: A Randomized Controlled Trial and Quality of Life Assessment

Status
Completed
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
80 (actual)
Sponsor
Montefiore Medical Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine whether bacterial decolonization of the nares and skin prior to treatment with radiotherapy (RT) for patients with cancers of the head and neck or breast, can prevent high-grade radiation dermatitis (RD) and improve quality of life. This study is being conducted because prior studies from this research group have found bacterial colonization in the nose prior to initiation of RT to be associated with an increased risk of high-grade RD. Patients in the treatment arm will receive pretreatment with mupirocin ointment to the nares and chlorhexidine wash to the body while patients in the control arm will receive standard of care treatment. Bacterial cultures will be taken from the nares and skin, and participants will also complete a quality of life questionnaire before and after RT.

Conditions

Interventions

TypeNameDescription
DRUGChlorhexidine gluconate solutionPatients in the intervention arm will receive a decolonization regimen, consisting of intranasal mupirocin ointment to be applied twice daily to the nares and chlorhexidine wash to be used once daily to the body.
DRUGMupirocin OintmentPatients in the intervention arm will receive a decolonization regimen, consisting of intranasal mupirocin ointment to be applied twice daily to the nares and chlorhexidine wash to be used once daily to the body.

Timeline

Start date
2019-06-03
Primary completion
2021-12-02
Completion
2021-12-02
First posted
2019-03-21
Last updated
2023-11-13
Results posted
2023-11-13

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT03883828. Inclusion in this directory is not an endorsement.